Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Uncontrolled, Two-centre, RSA, Post-market Surveillance Study to Evaluate the Stability of the C-Stem™ AMT Femoral Component in Primary Total Hip Arthroplasty.

NCT00872573 is registered in ClinicalTrials.gov with DePuy International as lead sponsor.

NCT NCT00872573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00872573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Uncontrolled, Two-centre, RSA, Post-market Surveillance Study to Evaluate the Stability of the C-Stem™ AMT Femoral Component in Primary Total Hip Arthroplasty.
Lead sponsor
DePuy International
Phase
Phase 4
Overall status
Terminated
Start date
July 1, 2006
Completion date
October 1, 2007
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, collagen disorders, congenital hip dysplasia, nonunion of femoral fractures, osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, slipped capital femoral epiphysis, traumatic femoral fractures